New Breast Cancer Research Says Some Patients Can Skip Chemotherapy
As many as 70 percent of women with the most common form of breast cancer may be able to skip chemotherapy, based on their score on a genetic test, researchers said Sunday. Until now, women have faced a great deal of uncertainty about whether to add chemo to hormone therapy after a diagnosis with hormone-receptor positive, HER-2 negative breast cancer at an early stage before it has spread to the lymph nodes.